New mutations and genotype–phenotype correlation in late-onset Pompe patients
- 28 December 2016
- journal article
- research article
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 117 (1) , 269-275
Abstract
Pompe disease is a glycogen storage disease caused by acid alfa-glucosidase deficiency. Here, we report clinical properties, genetic features of our late-onset Pompe patients. Seven patients were followed during the last 10 years in our institute. The clinical and laboratory findings were reviewed. Neuropsychological evaluation was performed in four patients. Myotonic discharges of paraspinal muscles and denervation potentials were seen in all patients at the diagnosis and were disappeared during follow-up in two. Only one patient, whose MRI showed cerebral atrophy, had attention and executive dysfunction. Compound heterozygous patients with IVS 1-13T>G have a milder disease. One patient who has homozygous IVS 1-13T>G mutation had more severe disease. Two of our patients who had very severe and fatal disease course carry double mutations on both alleles (c.547-39T>G and c.858+5ins7) that previously scored as “unknown” in Erasmus Pompe Center database. Lastly, we found new mutations (c.1209 C>A, 2737dupG) in two patients carrying IVS 1-13T>G in the other allele. Systemic involvements are very rare in late-onset Pompe patients. Similarly, Pompe disease does not cause cognitive impairment in adult population. Homozygous IVS 1-13T>G mutation and c.547-39T>G mutation which are previously noted as “unknown” pathogenicities cause a more severe disease.Keywords
This publication has 23 references indexed in Scilit:
- Toward deconstructing the phenotype of late‐onset Pompe diseaseAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2012
- The clinical and electrodiagnostic characteristics of Pompe disease with post-enzyme replacement therapy findingsClinical Neurophysiology, 2011
- Later-Onset Pompe Disease: Early Detection and Early Treatment Initiation Enabled by Newborn ScreeningThe Journal of Pediatrics, 2011
- Diagnostic criteria for late‐onset (childhood and adult) pompe diseaseMuscle & Nerve, 2009
- Development of a clinical assay for detection of GAA mutations and characterization of the GAA mutation spectrum in a Canadian cohort of individuals with glycogen storage disease, type IIMolecular Genetics and Metabolism, 2007
- Broad spectrum of Pompe disease in patients with the same c.-32-13T→G haplotypeNeurology, 2007
- Mutation profile of theGAA gene in 40 Italian patients with late onset glycogen storage disease type IIHuman Mutation, 2006
- Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human α-Glucosidase From MilkPediatrics, 2004
- Adult acid maltase deficiencyMuscle & Nerve, 1993
- ACID MALTASE DEFICIENCY IN ADULTS: STUDIES IN FOUR CASES OF A SYNDROME WHICH MAY MIMIC MUSCULAR DYSTROPHY OR OTHER MYOPATHIESBrain, 1970